Search

Lindsay A Hinkley

from Lincoln University, PA
Age ~47
Get Report
Also known as:
Lindsay A Zych, Ann Hinkley Lindsay, Hinkley Lindsay
Phone and address:
201 Highland View Dr, New London Township, PA 19352
Related to:
Erin M Ayers, 45William C Hinkley, 77Shawn D Zych, 69Ann Hinkley Lindsay, 47Phyllis H Hinkley, 76Andrew W Hinkley, 47John M Zych, 72Adeline M Zych
Connected to:
Annmarie E Hinkley, 57Bryan P Hinkley, 52Charles Hinkley, 63Danielle Hinkley, 39Douglas Hinkley, 46Kelsey A Hinkley, 35Kenneth E Hinkley, 62Libby Hinkley, 50Linda Hinkley, 70Nicholas A Hinkley, 41

Lindsay Hinkley Phones & Addresses

  • 201 Highland View Dr, Lincoln Univ, PA 19352
  • Lincoln University, PA
  • Cary, NC
  • Raleigh, NC
  • Binghamton, NY
  • Chester, PA
  • Wade, NC
  • Lincoln Univ, PA

Work

Company: Critical path services, llc Jul 2013 Position: Supervisor, cmc support services

Education

Degree: Masters of Science School / High School: North Carolina State University 1999 to 2002 Specialities: Organic Chemistry

Skills

Drug Discovery • Chemistry • Organic Synthesis • Drug Development • Hplc • Organic Chemistry • Technical Writing • Gmp • Regulatory Submissions • Chromatography • Analytical Chemistry • Biopharmaceuticals • Medicinal Chemistry • Lc Ms • Glp • Laboratory • Drug Design • Scientific Writing • Dossier Preparation • Six Sigma • Data Management • Project Management • Cmc • Cgmp • Data Analysis • Technical Review

Industries

Biotechnology

Resumes

Resumes

Lindsay Hinkley Photo 1

Senior Submissions Manager, Cmc Dossier Development

View page
Location:
Collegeville, PA
Industry:
Biotechnology
Work:
Critical Path Services, LLC since Jul 2013
Supervisor, CMC Support Services
Critical Path Services, LLC since Feb 2011
Technical Writer
Critical Path Services, LLC Nov 2011 - Jul 2012
Project Manager
AstraZeneca Pharmaceuticals Feb 2006 - Dec 2010
Senior Associate Scientist, Associate Scientist
Serenex, Inc Jul 2002 - Feb 2006
Associate Scientist II
Education:
North Carolina State University 1999 - 2002
Masters of Science, Organic Chemistry Le Moyne College 1995 - 1999
Bachelor of Science, Chemistry Chenango Forks High School 1991 - 1995
diploma
Skills:
Drug Discovery
Chemistry
Organic Synthesis
Drug Development
Hplc
Organic Chemistry
Technical Writing
Gmp
Regulatory Submissions
Chromatography
Analytical Chemistry
Biopharmaceuticals
Medicinal Chemistry
Lc Ms
Glp
Laboratory
Drug Design
Scientific Writing
Dossier Preparation
Six Sigma
Data Management
Project Management
Cmc
Cgmp
Data Analysis
Technical Review

Publications

Us Patents

Alkyl-Linked Nucleotide Compositions

View page
US Patent:
7371852, May 13, 2008
Filed:
Jan 21, 2004
Appl. No.:
10/762078
Inventors:
Klass P. Hardeman - Chapel Hill NC, US
Steven E. Hall - Chapel Hill NC, US
Roy W. Ware - Raleigh NC, US
Lindsay A. Hinkley - Raleigh NC, US
Matthew G. Jenks - Durham NC, US
Assignee:
Serenex, Inc. - Durham NC
International Classification:
C07H 21/00
G01N 33/566
G01N 33/543
US Classification:
536 253, 536 2533, 536 2622, 536 2623, 536 2626, 536 267, 536 268, 436501, 436518
Abstract:
Alkyl-linked nucleotide non-homogeneous solid supports and nucleotide affinity media comprising an alkyl-linked nucleotide are provided. The linker is generally a hydrophobic linker that can be a 3, 4, 5, 6, 7, 8, 9, 10, or a longer carbon chain. Also included in the invention are methods for synthesis of an alkyl-linked nucleotide, nucleotide affinity media and methods of use thereof for affinity chromatography and screening methods.

Benzene, Pyridine, And Pyridazine Derivatives

View page
US Patent:
7906529, Mar 15, 2011
Filed:
Dec 19, 2007
Appl. No.:
11/959784
Inventors:
Kenneth He Huang - Chapel Hill NC, US
Jeron Eaves - Durham NC, US
Gunnar Hanson - Dallas TX, US
James Veal - Apex NC, US
Thomas Barta - Carrboro NC, US
Lifeng Geng - Cary NC, US
Lindsay Hinkley - Cary NC, US
Assignee:
Serenex, Inc. - Durham NC
International Classification:
C07D 209/00
A01N 43/42
US Classification:
514299, 548452
Abstract:
Disclosed are compounds and pharmaceutically acceptable salts of Formula I.

Benzene, Pyridine, And Pyridazine Derivatives

View page
US Patent:
7928135, Apr 19, 2011
Filed:
Oct 19, 2010
Appl. No.:
12/907571
Inventors:
Kenneth He Huang - Northbrook IL, US
Jeron Eaves - Durham NC, US
Gunnar Hanson - Dallas TX, US
James Veal - Apex NC, US
Thomas Barta - Carrboro NC, US
Lifeng Geng - Cary NC, US
Lindsay Hinkley - Cary NC, US
Assignee:
Serenex, Inc. - Durham NC
International Classification:
C07D 231/54
A01N 43/56
US Classification:
514403, 5483601
Abstract:
Disclosed are compounds and pharmaceutically acceptable salts of Formula I.

Benzene, Pyridine, And Pyridazine Derivatives

View page
US Patent:
8309548, Nov 13, 2012
Filed:
Apr 7, 2011
Appl. No.:
13/081637
Inventors:
Kenneth He Huang - Northbrook IL, US
Jeron Eaves - Durham NC, US
Gunnar Hanson - Dallas TX, US
James Veal - Apex NC, US
Thomas Barta - Carrboro NC, US
Lifeng Geng - Cary NC, US
Lindsay Hinkley - Cary NC, US
Assignee:
Serenex, Inc. - Indianapolis IN
International Classification:
A61K 31/5377
A61K 31/454
A61K 31/415
A61K 31/405
C07D 413/12
C07D 401/12
C07D 403/12
C07D 209/04
US Classification:
5142352, 514323, 514403, 514415, 544144, 546201, 5483611, 548469
Abstract:
Disclosed are compounds and pharmaceutically acceptable salts of Formula I.

Substituted Quinoline And Quinazoline Inhibitors Of Quinone Reductase 2

View page
US Patent:
20060074105, Apr 6, 2006
Filed:
Sep 16, 2005
Appl. No.:
11/228833
Inventors:
Roy Ware - Raleigh NC, US
Lindsay Hinkley - Cary NC, US
Klaas Hardeman - Laarne, BE
Matthew Jenks - Durham NC, US
Assignee:
Serenex, Inc. - Durham NC
International Classification:
A61K 31/4709
C07D 401/02
C07D 215/38
US Classification:
514313000, 546159000
Abstract:
The present invention provides composition and methods of inhibiting quinone reductase 2 (QR2). The methods are useful in the treatment of malaria and autoimmune diseases. The compositions of the invention comprise quinoline and quinazoline derivatives. The invention also provides methods for inhibiting the activity of QR2 by contacting the enzyme with one or more compositions of the invention.

Benzene, Pyridine, And Pyridazine Derivatives

View page
US Patent:
20060211737, Sep 21, 2006
Filed:
Feb 27, 2006
Appl. No.:
11/363449
Inventors:
Kenneth Huang - Northbrook IL, US
Jeron Eaves - Durham NC, US
Gunnar Hanson - Dallas TX, US
James Veal - Apex NC, US
Thomas Barta - Carrboro NC, US
Lifeng Geng - Cary NC, US
Lindsay Hinkley - Cary NC, US
International Classification:
A61K 31/4439
A61K 31/4162
A61K 31/404
C07D 403/02
C07D 405/02
C07D 409/02
US Classification:
514338000, 514406000, 514414000, 546275700, 548465000, 548361500
Abstract:
Disclosed are compounds and pharmaceutically acceptable salts of Formula I wherein R, R, R, R, R, R, R, n, Q, Q, Q, Y, and X-Xare as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.

2-Aza-Bicyclo[2.2.1]Heptane Compounds And Uses Thereof

View page
US Patent:
20120094995, Apr 19, 2012
Filed:
Jan 27, 2010
Appl. No.:
13/146461
Inventors:
Jeffrey Scott Albert - Montreal, CA
Donald Andisik - Wilmington DE, US
Cristobal Alhambra - Montreal, CA
Todd Andrew Brugel - Wilmington DE, US
Glen E Ernst - Wilmington DE, US
William Frietze - Wilmington DE, US
Lindsay Hinkley - Wilmington DE, US
Jeffrey Gilbert Varnes - Boston MA, US
Xia Wang - Wilmington DE, US
Hui Xiong - Boston MA, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/407
A61P 25/18
A61P 25/22
A61P 25/00
A61K 31/506
A61P 25/04
A61K 31/4439
A61K 31/4155
A61K 31/422
A61K 31/5377
C07D 487/08
A61P 25/24
US Classification:
5142332, 548452, 514413, 5462767, 514339, 548468, 5483647, 514406, 548231, 514376, 544143, 544335, 514256
Abstract:
This invention relates to 2-aza-bicyclo[2.2.1]heptane compounds (and salts thereof), the process for making such a compound and pharmaceutical compositions comprising such a compound. The invention also relates to the use of the compounds for modulating the glycine transporter 1 (GlyT1) and for the treatment of psychosis, cognitive disorders, bipolar disorders, depression disorders, anxiety disorders, post-traumatic stress disorders and pain.

Benzene, Pyridine, And Pyridazine Derivatives

View page
US Patent:
20130137686, May 30, 2013
Filed:
Nov 5, 2012
Appl. No.:
13/669016
Inventors:
Jeron Eaves - Durham NC, US
Gunnar Hanson - Dallas TX, US
James Veal - Apex NC, US
Thomas Barta - Carrboro NC, US
Lifeng Geng - Cary NC, US
Lindsay Hinkley - Cary NC, US
International Classification:
C07D 209/08
A61K 31/454
A61K 31/416
A61K 31/404
C07D 413/12
A61N 5/10
C07D 231/54
C07D 403/12
C07D 405/12
C07D 409/12
A61K 45/00
A61K 31/5377
C07D 401/12
US Classification:
5142352, 514323, 514338, 514339, 514406, 514415, 544144, 546201, 5462757, 5462774, 5483611, 548469, 600 1
Abstract:
Disclosed are compounds and pharmaceutically acceptable salts of Formula Iwherein R, R, R, R, R, R, R, n, Q, Q, Q, Y, and X-Xare as defined herein. Compounds of Formula I are useful in the treatment of diseases and/or conditions related to cell proliferation, such as cancer, inflammation, arthritis, angiogenesis, or the like. Also disclosed are pharmaceutical compositions comprising compounds of the invention and methods of treating the aforementioned conditions using such compounds.
Control profile
Lindsay A Hinkley from Lincoln University, PA, age ~47 Get Report